World's Best Scientists 2026 revealed!
Adrian M. Di Bisceglie

Adrian M. Di Bisceglie

D-Index & Metrics

Medicine

D-Index
111
Citations
61079
World Ranking
5251
National Ranking
2833

Overview

Adrian M. Di Bisceglie is affiliated with Saint Louis University in the United States and has contributed extensively to the field of medicine, focusing primarily on epidemiology and hepatology. Their research output encompasses a variety of topics including liver disease diagnosis and treatment, hepatitis C virus research, hepatitis B virus studies, liver disease and transplantation, systemic lupus erythematosus research, berberine and alkaloids research, and liver diseases and immunity.

Among their recent publications are:

  • DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort, 2020, Journal of Hepatology
  • A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes, 2021, Nature Communications
  • Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development, 2020, Journal of Autoimmunity
  • Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis, 2020, Drug Safety
  • Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy, 2020, Hepatology

Di Bisceglie frequently collaborates with several researchers, including:

  • Michael Fried
  • Norah A. Terrault
  • Marc G. Ghany
  • Anna S. Lok
  • Richard K. Sterling

Their work has been published in various notable venues such as:

  • UNC Libraries
  • Journal of Hepatology
  • The American Journal of Gastroenterology
  • Alimentary Pharmacology & Therapeutics
  • Drug Safety

The primary fields of study for Di Bisceglie lie within medicine, with a significant number of publications in epidemiology and hepatology. Subfields also include pharmacology, rheumatology, and infectious diseases. The topics covered broadly focus on liver-related conditions and diseases, with particular attention to viral hepatitis, liver immunity, and treatment approaches involving pharmacological agents such as berberine.

Best Publications

  • Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

    Elizabeth M Brunt;Christine G Janney;Adrian M Di Bisceglie;Brent A Neuschwander-Tetri

  • Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie

  • EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

    Josep M. Llovet;Michel Ducreux;Riccardo Lencioni;Adrian M. Di Bisceglie

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

    A. M. Di Bisceglie;P. Martin;C. Kassianides;M. Lisker-Melman

  • Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease

    N W Barton;R O Brady;J M Dambrosia;A M Di Bisceglie

  • Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

    Nezam Afdhal;K. Rajender Reddy;David R. Nelson;Eric Lawitz

  • Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

    Kris V. Kowdley;Stuart C. Gordon;K. Rajender Reddy;Lorenzo Rossaro

  • Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

    Hoofnagle Jh;Mullen Kd;Jones Db;Rustgi

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • Hepatitis C and hepatocellular carcinoma

    Adrian M Di Bisceglie

  • Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.

    W. Ray Kim;Steven L. Flamm;Adrian M. Di Bisceglie;Henry C. Bodenheimer

  • Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

    M.Akram Khan;Connie S Combs;Elizabeth M Brunt;Val J Lowe

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • Hepatocellular carcinoma: Diagnosis and treatment

    Alex S. Befeler;Adrian M. di Bisceglie

  • Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

    Adrian M. di Bisceglie;Zachary D. Goodman;Kamal G. Ishak;Jay H. Hoofnagle

  • Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

    Anna S. Lok;Richard K. Sterling;James E. Everhart;Elizabeth C. Wright

  • Hepatic failure and lactic acidosis due to fialuridine (fiau), an investigational nucleoside analogue for chronic hepatitis b

    Robin Mckenzie;Michael W. Fried;Richard Sallie;Hari Conjeevaram

  • Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima

  • NIH conference. Hepatocellular carcinoma.

    Di Bisceglie Am;Rustgi Vk;Hoofnagle Jh;Dusheiko Gm

Frequent Co-Authors

Jay H. Hoofnagle
Jay H. Hoofnagle National Institutes of Health
Xiaofeng Fan
Xiaofeng Fan Jilin University
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Marc G. Ghany
Marc G. Ghany National Institutes of Health
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Richard K. Sterling
Richard K. Sterling Virginia Commonwealth University
Jules L. Dienstag
Jules L. Dienstag Harvard University
Elizabeth M. Brunt
Elizabeth M. Brunt Washington University in St. Louis
Chihiro Morishima
Chihiro Morishima University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering alternative or complementary routes to a traditional medical degree? There are a variety of online programs that offer flexible career pathways in healthcare. For example, online health administration programs can prepare you for leadership roles within hospitals, clinics, and healthcare organizations—giving you management skills to help shape patient care at a higher level.

Nursing professionals seeking advancement can benefit from rn to np programs online, which provide a seamless transition from registered nurse to nurse practitioner qualifications, all through flexible online study.

If you're interested in preventative health and wellness, an online degree in nutrition opens the door to careers in nutrition counseling, public health, and wellness coaching.

Those aspiring to become future healthcare leaders should explore the best online mha programs, which focus on advanced healthcare administration accredited by leading bodies.

Each of these online degrees offers flexible, accredited options for professionals looking to impact healthcare without following the traditional path to becoming a physician.

Best Scientists Citing Adrian M. Di Bisceglie

Trending Scientists

Recently Published Articles